New Immunotherapies and Targeted Therapies to Treat Lymphoma

The 2017 American Society of Hematology (ASH) Annual Meeting was held last month in Atlanta, Georgia. This meeting brings together experts from across the globe so they can discuss new advances in the treatment of different types of blood-related diseases including a group of cancers called lymphoma. In this podcast, Michael E. Williams, MD, ScM, highlights some of the research presented at the meeting that may improve the treatment of lymphoma. A study examined whether adding brentuximab vedotin (Adcetris), a targeted therapy, to a chemotherapy combination used to treat Hodgkin…

Read More